Heat Shock Protein: Hard Worker or Bad Offender for Gastric Diseases by Lee, Ho-Jae et al.
Hindawi Publishing Corporation
International Journal of Proteomics
Volume 2010, Article ID 259163, 11 pages
doi:10.1155/2010/259163
Review Article
Heat Shock Protein: Hard Worker or Bad Offenderfor
GastricDiseases
Ho-Jae Lee,1 Chan YoungOck,2 Seong-JinKim,3 andKi-BaikHahm2,4
1Laboratory of Chemoprevention, Lee Gil Ya Cancer and Diabetes Institute, Gachon University of Medicine and Science,
Incheon, Republic of Korea
2Laboratory of Translational Medicine, Lee Gil Ya Cancer and Diabetes Institute, Gachon University of Medicine and Science,
Incheon, Republic of Korea
3Laboratory of Cell Regulation and Carcinogenesis, Lee Gil Ya Cancer and Diabetes Institute,
Gachon University of Medicine and Science, Incheon, Republic of Korea
4Department of Gastroenterology, Gachon Graduate School of Medicine Gil Medical Center, Songdo-dong 7-45,
Yeonsu-gu, Incheon, 406-840, Republic of Korea
Correspondence should be addressed to Ki-Baik Hahm, hahmkb@hotmail.com
Received 28 June 2010; Accepted 5 September 2010
Academic Editor: Ho Jeong Kwon
Copyright © 2010 Ho-Jae Lee et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Heat shock proteins (HSPs) have core housekeeping functions in the cells where they are built-in components of folding, signal
transduction pathways, and quality control functions for which they proofread the structure of proteins and repair misfolded
conformers. Helicobacter pylori (H. pylori) infection leads to signiﬁcant inﬂammations in the gastric mucosa, which is closely
associated with development of either precancerous lesion including chronic atrophic gastritis or gastric cancer in addition to,
peptic ulcer disease, and mucosa-associated lymphoid tissue (MALT) lymphoma. Therefore, the association between H. pylori
infection and role of HSP has been focused as an important issue because there had been rather conﬂicting publications showing
that HSPs as a good worker for defense against H. pylori infection, whereas HSPs as a bad oﬀender contributing to the progression
of H. pylori-associated gastric carcinogenesis in addition to aggravation of gastric inﬂammation. In this paper regarding proteomic
discovery of HSPs related to H. pylori-associated gastric diseases, we introduce several evidences obtained from proteomic analysis
dealing with friend or foe role of HSP in H. pylori infection from a cellular level to human diseases. The implication of HSPs in
alcoholic or NSAIDs-induced gastritis and the intervening of HSPs in biological changes exempliﬁed with TGF-β signaling, key
tumor suppressor growth factors regulating inﬂammation, immune function, and carcinogenesis were further introduced.
1.Introduction
Epithelial cells in gastrointestinal (GI) tract are continuously
exposed to a lot of stressful antigens because we eat diﬀerent
meals 3 times a day and swallow air pollutant into GI
tract. Moreover, they are harassed to several kinds of gas
produced by commensal bacteria colonized in GI tract. To
cope with this very stressful organization and environment,
GI mucosa wisely developed various strategies to tolerate
stresses, such as generating antioxidant enzymes, increasing
level of immune-tolerance, and regulating mechanisms to
cope with stress like chaperone genes including heat shock
proteins (HSPs). HSPs are groups of stress-response proteins
which are either constitutively expressed or induced through
the transcriptional action of heat shock factor (HSF). HSPs
are classiﬁed into four major families according to their
biological activities and apparent molecular weights; HSP90,
HSP70, HSP60, and small HSPs including HSP27. While
HSP60, HPS70, and HSP90 are constitutively expressed,
HSP70 and HSP27 are induced by various conditions,
including heat, oxidative stress, or drug exposure. The type
of HSP induced and its level of expression can determine
the fate of a cell in response to stress or stimulus, by which
HSPs may play a cytoprotective role in gastrointestinal tract.
For instances, oral administration of geranylgeranylacetone
(GGA), an antiulcer drug, rapidly induced HSP70 in rat2 International Journal of Proteomics
gastric mucosal cells and the induced HSPs contributed
to the suppression of inﬂammation accompanied with
accelerated healing of ulcer induced by water immersion
restraint stress. Animal studies have consistently demon-
strated that though H. pylori infection delays gastric mucosal
healing by disrupting the balance in cell apoptosis and
proliferation, decreasing migration of epithelial cells, and
decreasing blood ﬂow and angiogenesis within the gastric
mucosa, HSPs could reverse these limitation and inferiorities
in mucosal healing.
The general roles of HSP are intracellular cleaning of
wasted product due to stress, after which are nominated
as molecular chaperone, of which functions are as fol-
lows brieﬂy: (1) assisting folding of translated proteins,
(2) importing proteins into subcellular compartment, (3)
disassembling oligomeric protein structures, (4) inducing
proteolytic degradation of unstable proteins, (5) controlling
the biological activity of folded regulatory proteins, and
(6) endogenous modulation of apoptosis execution [1–4].
Interestingly in contrast to these protective roles for mam-
malian cells, HSPs could facilitate cell damage and promote
carcinogenesis. Moreover, increasing evidences showed that
not only mammalian cells have HSPs, but also bacteria such
as Helicobacter pylori (H. pylori) have HSPs either to survive
against hostile host oﬀense system or to disrupt host defense
system.
Therefore, this bifunctional signiﬁcance of HSPs as
“worker” based on contribution to the strengthening gastric
defense system or “oﬀender” based on weakening gastric
defense system besides of molecular mimicry prone to
autoimmune in gastric diseases is one of intriguing issues
in gastroenterology. Here in this paper, we present double-
edged roles of HSPs in H. pylori or alcohol-associated
gastritis, followed with the novel strategy that HSPs can be
a target for treatment or diagnostic biomarker for predicting
the progression of gastric disease all documented with
proteomic approach. Brief workﬂow for proteomic approach
will also be introduced before HSP-related research in gastric
diseases.
2. Workﬂow for Proteomic Biomarker
Discoveryof GastricDiseases
Every patient, even diagnosed with same disease, has diﬀer-
ent proﬁle of gene or protein expression, a very important
starting point of view for tailored medicine. To ﬁnd out the
common proﬁle of a subset of patients with same disease is
oneofchallengingissuesfromlate1990s.Usinggenomicdata
originated from Human Genome Project (HGP), we could
reloadapowerfulbulletinourhandstoanalyzethesimilarity
or diﬀerence of gene expression proﬁle of patients, after
which it has not taken long to ﬁnd out that there were a lot
moreregulationabovethesimplesequenceofgenesandtheir
expression such as epigenetic regulation or posttranslational
regulation. Conclusively, “proteomics” approach including
2D-PAGE and mass spectrometry is indispensible in order
to understand global protein expression and modiﬁcation
proﬁle. Using these cutting edge techniques, we could
understand the whole protein status at a glance instead of
old-fashioned technique of molecular biology which would
have consumed a lot more time and eﬀorts and touched the
modiﬁcation of whole protein in a rather easy way [5, 6].
One of very useful applications of proteomics is developing
clinical biomarker to predict the existence or severity of
diseases.
Potential biomarkers would be suggested by comparing
the protein proﬁle of patients with that of normal people,
after which we could verify the signiﬁcance of this biomarker
by analyzing large-scaled clinical study. The biologic role of
this potential biomarker would be validated by conventional
molecular biological technique. If the quantitative level of
potential biomarkercorrelateswellwithseverity ofdiseaseor
progression of inﬂammation-carcinogenesis sequence, this
marker is not only useful in clinical screening but also
in studying pathogenesis of disease. Therefore, proteomics
research has been developed as a fancy bridge from bench
to bed side, especially in understanding diseases which have
“inﬂammation-carcinogenesis” sequence [7].
Before the era of “omics,” clinician diagnosed the patient
with his/her own clinical impression based on medical
history and physical examination. This basic technique of
“taking care of” patient was the most fundamental, but very
important manner to a clinician. However, as increasing
level of understanding pathophysiology of diseases and as
increasing capacity of clinical data, this trial-error approach
or experience-based manner shows the limitation in indi-
vidualization of patient care, necessitating the need of
“dissecting” his/her biologic proﬁles with the technique of
genomics, transcriptomics, proteomics, and metabolomics.
After routine history taking and physical examination,
patient samples such as bloods, tissues, or bioﬂuids would be
gatheredingastroenterologyclinicsandwouldbetransferred
to 3 diﬀerent pipelines, comprising of single nucleotide
polymorphism (SNP) pipeline, transcriptomics pipeline,
and proteomics pipeline. Though case-control study is one
example of clinical study methods using analyzing correla-
tion between disease status and SNP status, whether SNP is
diﬀerent between patients’ and controls’ could not conﬁrm
that it aﬀects real biologic diﬀerence because SNP may not
involve in transcriptional regulation. We could solve this
problem to analyzing whole transcriptional regulations by
microarray or protein-array methods, so-called “transcrip-
tomics.” However, soon beyond-transcriptional regulation
became more important in biologic consequences. Post-
translational modiﬁcation such as phosphorylation, glyco-
sylation, protein folding, protein traﬃcking, and protein-
protein interaction would be caught by proteomics pipeline.
This pipeline includes 2-dimensional electrophoresis and
mass spectrometry. Using these three kinds of pipeline,
we could gather amount of information about patients’
biologic status. These abundant, ambiguous, and sometimes
nonspeciﬁc data will be analyzed and validated by statistical
signiﬁcance, after which data will be compared with clinical
outcomes. At last using this workﬂow, we could understand
the important pathophysiologic mechanism of diseases, and
suggest more validated strategy to individual patient due to
statistical evidence (Figure 1).International Journal of Proteomics 3
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Figure 1: Workﬂow for discovering potential biomarkers of gastric diseases. HGP contributed to development of either the concept of
high-throughput analysis or pipeline for experimental technology, including SNP discovery, transcriptomics, proteomics, metabolomics,
clinomics, and glycomics. Proteomic pipeline for serum biomarker discovery, pathogenic proteins elucidation, and precision medicine is
actively working for tailored medicine.
3.Host Heat ShockProtein(HSP)in
H. pylori Infection: Roles as
Hard Worker or Bad Offender
3.1. HSP as Hard Worker. Gastric surface mucous cells are
the ﬁrst line of defense against insults like ingested foods,
nonsteroidal anti-inﬂammatory drugs (NSAIDs), alcohol,
and H. pylori infection [8], within which HSPs are crucial
for the maintenance of epithelial homeostasis during normal
cell growth and for survival during and after various cellular
stresses, supported with their molecular chaperone and
cytoprotective actions like either protecting mitochondria
or interfering with the stress-induced apoptotic programme
[9]. In order to document the contribution of HSPs after
H. pylori infection, ﬁrst we performed two-dimensional
electrophoretic analysis in order to check any shifts in
HSP proﬁles after H. pylori infection [10]. As results, H.
pylori infection signiﬁcantly attenuated the expression of
HSP70 whereas exposure of cells to noncytotoxic heat shock
or geranylgeranylacetone (GGA), an HSP inducer, restored
HSP70 expression, as well as suppressing the expression
of iNOS, a major inﬂammatory mediators provoking H.
pylori-induced gastric tissue damage. Our results suggest
that induction of HSP70 confers cytoprotection against H.
pylori infection by inhibiting the expression of iNOS. These
results provided important insights into the ﬂux in HSPs
proﬁles in response to H. pylori infection and highlighted
the cytoprotective role of HSP70 in H. pylori infection.
Since paradoxically H. pylori have been found to decrease
expression of HSPs, Axsen et al. [11] investigated whether
this phenomenon of HSP downregulation is speciﬁc to H.
pylori or not. As results, coculture of H. pylori with two
gastric carcinoma cell lines reduced expression of HSP70
and,toalesserextent,HSP60.DownmodulationofHSPswas
not dependent on the presence of the vacuolating cytotoxin
(vacA) or the cag pathogenicity island (cag PAI) whereas
the bacterial pathogen, S. typhimurium, upregulated HSP
expression reversely. Therefore, though sometimes HSPs
are thought to function as danger signals during microbial
infection, H. pylori-induced downregulation of HSPs could4 International Journal of Proteomics
be a mechanism of immune evasion that promotes chronic
infection [12].
Next, in order to verify these attenuations of HSP70,
documented as “hard worker” for enhancing gastric mucosal
defense, after H. pylori infection, we have compared the
proteomes between H. pylori-not-associated asymptomatic
stomach and H. pylori-associated chronic gastritis. Very
interestingly, one of signiﬁcant changes was “decreased
HSP70 level” in H. pylori-associated chronic superﬁcial
gastritis patients (Figure 2(a)), similar ﬁnding as noted in
the above cellular system. As mentioned above, since HSP70
proteins assist a wide range of folding processes, including
the folding and assembly of newly synthesized proteins,
refolding of misfolded and aggregated proteins, membrane
translocation of organellar and secretory proteins, and
control of the activity of regulatory proteins [9], HSP70
proteins have additional housekeeping functions in balanc-
ing cellular homeostasis. Decreased HSP70 expression in H.
pyloriinfectionhasbeenreportedingastricepithelialcellline
[13]a n din vivo animal studies [14]. In conclusion, HSPs
are ﬁnely regulated in a response to various extracellular
stresses and reversely the disruption of HSPs regulation
might result in fatal consequence of gastric disease status.
Thesebiologic meaningssigniﬁcantlycorrelatedwithclinical
outcome strongly suggested that HSPs are “hard worker” for
gastric defense. Then, curiosity arose that how about the
changes of other subfamily of HSPs, for instance, HSP90
or HSP27 in H. pylori infection? Since HSP90 has been
revealed to be critical for intracellular signaling that partic-
ipates in inﬂammatory response as well as carcinogenesis
[14], we have investigated a regulatory role of HSP 90
in H. pylori-induced IL-8 production [15], showing that
H. pylori stimulated signiﬁcant phosphorylation of HSP90,
but the phosphorylation was diminished by administration
of HSP 90 inhibitor, geldanamycin (GA). Treatment of
GA completely inhibited H. pylori-induced IL-8 production
through the deactivation of ERK1/2 and NF-κB. These
results subsequently lead to inactivation of AP-1 and NF-κB,
which are known to be major transcriptional factors of IL-
8. Our investigation provides important insights that HSP90
is involved as a crucial regulator in the production of H.
pylori-induced IL-8 chemokine and HSP90 inhibitor could
be potentially used for the inhibition of H. pylori-provoked
inﬂammation. Though HSPs seemed to be “hard worker”
for gastric defense, reckless induction of HSPs can confront
unwanted disaster, leaving the precept “much is not always
good.”
3.2. HSP as Bad Oﬀender. Reversely to “hard worker”
role of HSPs, exposure of cells to microbial pathogens
also induced HSPs, which then modulated both innate
and adaptive immune responses, led to “bad oﬀender” to
perpetuating gastric inﬂammation or inducing autoimmune
gastritis [16]. H. pylori infection induces autoantibodies
that cross-react with human gastric mucosa from infected
individuals. Candidates for the antigens responsible for
molecular mimicry causing autoreactivity include the HspB
(HSP60, sometimes called HSP54) or Lewis x and Lewis y
carbohydrate antigens. Pierzchalski et al. [12] determined
whether apoptosis induced in the gastric epithelium exposed
to live H. pylori might occur due to either the elimination
of HSP70 expression or deregulation of the heat shock
response of the cell. What they have elucidated was that H.
pylori infection induces autoantibodies that cross-react with
human gastric mucosa from infected individuals. Infection
with H. pylori induces humoral immune responses against
various antigens of the bacterium, among which HSPs are
immunodominant antigens. All of these results suggested
that HSPs contributed to H. pylori colonization, facilitated
mucosal infection, and promoted inﬂammation. Therefore,
under the hypothesis that proteomic approach can provide
the insights enable to pull out biomarkers for predicting
the progression of gastritis and risk factors for gastric car-
cinogenesis, we have checked and compared the pulled-out
proteomes from asymptomatic cases, symptomatic chronic
superﬁcial gastritis (CSG), chronic atrophic gastritis (CAG)
accompanied with intestinal metaplasia (IM), and gastric
cancer (GC). Gastric inﬂammation is a well-known example
of inﬂammation-carcinogenesis sequence (Figure 2(b)). In
an analysis, to simply focused on ﬁnding proteins whose
expression sequentially increases or decreases as disease
progress from H. pylori-associated asymptomatic case to
gastriccancer.Asresults,oneofsigniﬁcantchangeswasserial
increment of “HSP27” (Figure 2(c)) and “MAPKK” (Fig-
ure 2(d)) level, the mean levels of which were signiﬁcantly
increasedasdiseaseprogressfromasymptomatic,CSG,CAG,
to gastric cancer. Generally, in response to extracellular
stress such as heat, oxidative stress, or anticancer agents,
the small HSPs and HSP70 are induced while HSP90 and
HSP60 are constitutively expressed. HSP27 was reported
to increase the antioxidant defense of mammalian cells
by increasing the level of reduced glutathione, GSH, and
decreasing reactive oxygen species (ROS) [5]. By the way,
in spite of these protective eﬀects against cellular stress,
increased expressions of HSP27 were also reported in a
variety of cancers, for which it was reported that HSP27
induces antiapoptotic activity [4, 17–19]. Therefore, step-
by-step increasing expression of HSP27 in progression of
gastritis to premalignant condition cancer may be explained
by either insuﬃcient protective eﬀect or directly harmful
eﬀect of HSP27, all of these plausible mechanisms might
be associated with the progression and deepening of gastric
inﬂammation. Another other potential biomarker for these
aggravations of gastritis was increase in MAPKK, core signal
for inﬂammation cascade and carcinogenesis [20, 21].
Development of gastric mucosa associated lymphoid
tissue (MALT) lymphoma is thought to be closely associated
with host immune reactions to H. pylori.T oi n v e s t i g a t e
humoral immune responses in patients with MALT lym-
phoma to antigens shared by H. pylori and human gastric
epithelial cells, Kawahara et al. [22]s c r e e n e ds e r af r o m
H. pylori positive patients with MALT lymphoma and
other gastroduodenal diseases, all associated with H. pylori
infection. Immunoblotting of sera from patients with MALT
lymphoma often detected a band with a molecular mass cor-
responding to HSP60, and both ELISA and immunoblotting
showed elevated antibody titres to the recombinant human
HSP60, leading to that conclusion that autoantibodiesInternational Journal of Proteomics 5
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Figure 2: Proteomic dissection for potential biomarkers for disease progression and carcinogenesis. (a) Helicobacter pylori-associated chronic
superﬁcial gastritis was signiﬁcantly associated with attenuated levels of HSP70 as identiﬁed in previous publication [10]. (b) Biopsied
tissues obtained from diverse stage of H. pylori-associated gastric diseases were used for proteomic analysis. (c) On individual analysis after
(b),signiﬁcantcorrelationwasnotedbetweentheincreasedspotdensityofHSP27andtheprogressionof H.pylori-associatedgastricdisease,
conﬁrming previous publications that HSP27 can be one of potential biomarker for H. pylori-associated gastric diseases. (d) MAPKK can be
another candidate telling the progression of H. pylori-associated gastric diseases.
reactive with host gastric epithelial cells are often increased
in MALT lymphoma, and Hsp60 is a major target antigen.
Therefore, immune responses induced by immunological
cross reactivity between H. pylori HspB and human HSP60
in gastric epithelium may be involved in the development of
MALT lymphoma. Finally, HSP90 is a molecular chaperone
whose association is required for the stability and function
of multiple mutated, chimeric, and overexpressed signaling
proteins that can promote the growth and survival of cancer
cells since HSP90 client proteins include mutated p53, Bcr-
Abl, Raf- 1 ,A k t ,H E R 2 / Neu (ErbB2), and HIF-1α [23]. This
is why HSP90 has been identiﬁed as a critical regulator of
oncogenic protein and we have also published that H. pylori
infection is also associated with increased activity of these
oncogenic proteins in either inﬂammation perpetuation or
proliferative activities.
4. BacterialHeat Shock Protein:Role as
Foe in H. pylori Infection
Among H. pylori-infected patients, 80% remains asymp-
tomatic along life whereas 10% suﬀered from associated
disease including peptic ulcer and gastritis and less than
1% become the victim of gastric cancer [24], in which
divergence host genetic factor, environmental inﬂuence,
and bacterial virulence are known to be intercalated (Fig-
ure 3(a)). Although many H. pylori virulence factors have6 International Journal of Proteomics
been reported to be pathogenic, we could not discriminately
acknowledge those as potential biomarker. As shown in Fig-
ure 3(b), neither cagAn o rvacA genotype was not correlated
with clinical disease in spite of critical pathogenic contribu-
tion in our documentation in spite that the presence of cagA
is associated with increased risk of gastric adenocarcinoma
[25] and that statistical signiﬁcance exists between bacterial
genotype of CagA allele, VacA allele, and host disease status
[26]. Lin et al. [27] studied to identify gastric cancer-
related antigens from H. pylori using proteomic approach
and characterize their roles in the development of gastric
cancer. As results, the proteins showing higher frequency
of recognition in H. pylori-associated gastric cancer group
are as follows: threonine synthase, rod shape-determining
protein, S-adenosylmethionine synthetase, peptide chain
release factor 1, DNA-directed RNA polymerase alpha sub-
unit, cochaperonin GroES (monomeric and dimeric forms),
response regulator OmpR, and membrane fusion protein.
In a similar approach, Lin et al. found a potential role of
H. pylori HSP60 in gastric tumorigenesis. H. pylori HSP60
enhanced migration by gastric cancer cells and promoted
tube formation by umbilical vein endothelial cells and
triggered the initiation of carcinogenesis by inducing proin-
ﬂammatory cytokine release and by promoting angiogenesis
and metastasis. We also could ﬁnd that H. pylori HSP27 was
increased in bacteria cultured from mucosa of malignant
gastric ulcer patient compared to bacteria obtained from
mucosa of benign gastric ulcer patient, suggesting that
bacterial HSP27 may have roles for bacterial survival or
strength to attack host gastric mucosa, explaining functional
similarity of mammalian HSPs (Figure 3(c)).
5. Host Heat Shock Protein in
Non-H. pylori-AssociatedGastritis
5.1. HSP in Alcoholic Gastritis. Chronic alcohol consump-
tion is highly associated with gastric and ulcer which may
progress to gastric cancer. Alcohol-induced gastric mucosal
injury can be mediated by various cellular molecules such as
cyclooxygenase (COX), lipoxygenase (LOX), cytokines, and
oxygen-derived free radicals [28–30] whereas polyphenols
from green tea were reported to inhibit inﬂammation,
scavenge excess free radicals, and stimulate the regeneration
ofdamagedcellsortissues[31].Basedonthesebackgrounds,
we hypothesized that green tea extracts may attenuate
alcohol-induced gastric injury [32]. Figure 4(a) showed
that the gross and pathology of alcohol-induced gastric
damage and green tea extract pretreatment dramatically
reduced gastric hemorrhage and mucoid cap formation in
a dose-dependent manner. With green tea extracts, COX-2,
iNOS levels were signiﬁcantly decreased accompanied with
inhibition of NF-κ1, and MAPK pathway. However, in con-
trary to our expectation, HSP70 level was unchanged even
after green tea extract treatment (Figure 4(b)), necessitating
further to conﬁrm whether attenuating eﬀect of green tea
extract in alcoholic gastritis was not relevant to HSPs. To
analyze the diﬀerence of protein proﬁles between alcohol-
induced control and green tea extract pretreatment group,
we performed proteomic analysis. Interestingly, we found
HSP60andglucose-regulatedprotein58(GRP58)levelswere
signiﬁcantly increased in green tea extract, more apparent in
the activation of these proteins as documented with acidic
shift, suggesting that activation of HSPs with green tea was
engaged in these protections from alcoholic gastritis rather
than the levels of expression (Figure 4(c)). GRP58 is also
a member of ER stress response genes, its role is mainly
similar with HSPs’ [33]. This inducible ER chaperone may
be a diligent worker for coping with alcohol-induced cellular
stress. Interestingly two opposite points of view regarding
the role of HSPs also exists in alcoholic gastritis, imposing
H S Pa sw o r k e ro ro ﬀender in alcoholic damage. Kai et al.
[34] studied the degree of gastric mucosal damage against
70% ethanol following GGA or vehicle treatment in portal
hypertensive (PHT) rats because PHT gastropathy has an
increased susceptibility to damage due to noxious factors.
Ethanol-induced gastric mucosal damage was signiﬁcantly
decreased due to GGA treatment in the PHT rats, but not in
the sham-operated rats, suggesting that HSP70 expression is
enhancedinPHTgastricmucosaandplaysanimportantrole
in gastric mucosal protection. On the other hand, Tominaga
et al. [35] showed 10% ethanol pretreatment markedly
increases gastric HSP90 expression in PHT rats. Excessive
production of HSP90 may contribute to impaired adaptive
cytoprotection.
5.2. Host Heat Shock Protein in NSAID-Induced Gastropathy.
A major clinical problem encountered with the use of
NSAIDs such as indomethacin is gastrointestinal complica-
tions. Both NSAID-dependent COX inhibition and gastric
mucosal apoptosis are involved in NSAID-produced gastric
lesions, and this apoptosis is mediated by the endoplasmic
reticulum stress response and resulting activation of Bax.
Since HSPs have been suggested to protect gastric mucosa
from NSAID-induced lesions, we have tested the activation
of HSPs are engaged in protection from indomethacin
induced gastropathy using proteomic approach. NSAIDs
were closely associated with increased phosphorylation of
HSP27, after which the levels of HSP27 were signiﬁcantly
decreased through proteasomal degradation. Therefore, the
way of preserving the HSP27 can be the one of eﬃcient
modalities to stomach free from NSAIDs damages irrespec-
tive of COX activity.
6. TranslationalViewofHSP:AsExampledwith
CrosstalkbetweenHSPsandTGF-β Signaling
Among several kinds of HSPs, HSP90 is a ubiquitous molec-
ularchaperonewhoseassociationisrequiredforstabilityand
function of many signaling proteins. HSP90 client proteins
include a wide variety of signal transducing proteins that
regulate cell growth and diﬀerentiation such as transcription
factors, receptors, and protein kinases [37]. Recent studies
show that TGF-β signaling mediators including TGF-β
receptors, receptor-activated Smads, or inhibitory Smads
are regulated by ubiquitin-mediated downregulation as a
means to control signaling. Based on these backgrounds,International Journal of Proteomics 7
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Figure 3: Comparative proteomes of H. pylori related to gastric diseases. (a) Bacterial virulence factor, host factor, and environmental factor
mightinﬂuencetheoutcomeofH.pyloriinfection,disruptingthebalancebetweendamagingfactoranddefensefactor.(b)GenotypingofH.
pylorivirulencegeneaccordingtoisolatesdisease,CSGdenotesH.pyloriisolatedfromthepatientswithchronicsuperﬁcialgastritisandCAG
frompatientswithchronicatrophicgastritis.Thoughthesevirulencefactorscanaﬀectthediseasepathogenesis,theywerenotdiscriminative
indiﬀerentialdiagnosisasbiomarker.(c)SigniﬁcantlyincreasedspotofHSP27werenotedinH.pyloriisolatedfromgastriccancercompared
to benign gastric ulcer (lower panel). Using the sera obtained from the patient with gastric cancer, signiﬁcant immunoblotting was noted in
patients with gastric cancer, imposing the signiﬁcance as biomarker for carcinogenesis.
Knuesel et al. [36] demonstrated that Smad3 interacts with
HSP70 in vivo using a tandem aﬃnity puriﬁcation and mass
spectrometry, which might be the ﬁrst report indicating that
Smad3 is a client protein of HSP70 chaperone complex.
Smad3turnoverisregulatedbytheCHIP-(carboxyterminus
of Hsp70 interacting protein-) dependent degradation [38].
CHIP is a tetratricopeptide repeat- (TPR-) containing E3
ubiquitin ligase that binds to the molecular chaperones
HSC70-HSP70 and HSP90 [39]. Luo et al. [40] analyzed the
proteomicproﬁlingofSmad-interactingproteinsusingmink
lung epithelial cells, Mv1Lu cells, and showed that HSP70 is
one of interacting partners of Smad2 indicating that HSP70
possibly helps assemble or facilitate the formation of the
complex of Smad2 with its partners. Recent studies showed
that the chaperon protein HSP90 also positively regulates
TGF-β receptor activity. TGF-β type I and type II receptors
were found to interact with and be stabilized by HSP90.
Inhibition of HSP90 using small molecule inhibitors leads to
increased receptor ubiquitination, indicating that HSP90 is a
modiﬁerofSmurf2-mediatedTGF-β receptorubiquitination
[41]. However, still it is not clear whether HSP90 binding to
the receptors depends on and regulates the receptor kinase
activity. Since HSP90 functions as part of a multichaperone
complex via association with a set of cochaperone proteins8 International Journal of Proteomics
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Figure 4: Green tea-induced HSP for alcoholic gastritis. (a) Intragastric administration of ethanol to male Sprague-Dawley rats caused
signiﬁcantgastricmucosaldamageasshowngrossandpathologicﬁnding(a,b).Greenteaextract,50,100,and500mg/kg,showedsigniﬁcant
improvement in gastric pathology in a dose-dependent manner (c, d, e). (b) iNOS expressions were signiﬁcantly decreased as the dosing of
green tea extracts were increased whereas no signiﬁcant change in HSP70 was observed on Western blotting of iNOS and HSP70 [36]. (c)
Themucosal homogenateswere subjected to2D-PAGEandthespotswere comparedbetween alcoholic gastritisgroupandalcoholic gastritis
pretreated with 500mg/kg green tea extract. On mass spectroscopy, HSP60 and GRP58 were signiﬁcantly preserved with increased acidic
shifts.
that inﬂuence the maturation and stability of client proteins
[42], we have demonstrated that GA, an inhibitor of
HSP90 ATPase, signiﬁcantly suppresses TGF-β signaling.
GA-mediated induction of HSP70 interacts with TGF-β
type I and type II receptors and subsequently degraded
TGF-β receptors through a proteasome-dependent pathway
[43]. When we examined the eﬀects of each component of
HSP90chaperonecomplexonTGF-β signalingusingspeciﬁc
siRNAs, HSP70 played a major role in the GA-mediated
inhibition of TGF-β signaling. Besides chaperoning function
of HSPs, numerous reports have shown that the endogenous
or stress-induced expression of HSPs, particularly HSP70,
confer cellular protection against a variety of stresses and
also against physiological stresses associated with growth
arrest or receptor-mediated apoptosis. It has been shown
that preexposure to heat shock protects TGF-β induced
apoptosis of cultured hepatocytes with concomitant induc-
tion of HSP70 [44]. In addition, GGA attenuated TGF-β-
induced epithelial-mesenchymal transition (EMT) in renal
proximal epithelial cells and enhanced expression of HSP70
using adenoviral infection prevented TGF-β induced EMT
[45]. Recently, Zhou et al. [46] also demonstrated that
HSP70 inhibits EMT by antagonizing the activation and
translocation of Smad3 through domain speciﬁc interactionInternational Journal of Proteomics 9
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Figure 5: Suppression of HSP70 sensitizes TGF- β signaling. (a) NCI-H292 cells were transfected with HSP70 siRNA or control siRNA and
SBE4-luc, and then treated with TGF-β1( 5n g /ml) for 16hr. Luciferase activity was measured by a luminometer. (b) Cells transfected with
HSP70 siRNA or control siRNA treated with or without TGF-β1( 5n g /ml) for 24hr and stained with the PI DNA dye were subjected to cell
cycle analysis using FACS. The data were expressed as a histogram with the DNA content (FL2) along the X-axis. (c) Cells were transfected
with HSP70 siRNA or control siRNA treated with or without TGF-β1( 5n g /ml) for indicated time. Cell lysates were immunoblotted with
antibody speciﬁc to c-Myc, phospho-Smad2, or HSP70.
with Smad3. To address whether suppression of HSP70
could sensitize the TGF-β-induced transcriptional activity
and growth arrest in epithelial cell, NCI-H292 cells were
transfected with HSP70 siRNA and examined the TGF-β-
induced reporter activity and cell cycle analysis. As shown
in Figure 5, suppression of HSP70 resulted in about 2-
fold increase in luciferase activity and the TGF-β dependent
increase in the percentage of cells accumulating in G0/G1.
Knockdown of HSP70 alone did not lead to increase in
G0/G1 phase compared to control siRNA. To conﬁrm the
physiological role of HSP70 in TGF-β signaling, we did
perform Western blot analyses using lysates from NCI-H292
cellstransfectedwith HSP70 siRNA. Thelevel of endogenous
HSP70 expression was signiﬁcantly reduced that resulted
in a decrease in TGF-β-induced downregulation of c-Myc.
Suppression of HSP70 also resulted in an increase in TGF-
β-induced phosphorylation of Smad2. These data suggested
that endogenous HSP70 acts as a negative modulator in
TGF-β signaling partially independent of HSP90 activity.
However, the exact molecular mechanism underlying the
inhibition of TGF-β signaling pathway requires further
investigation.
7. Conclusion
With the discovery of gastric acids and pepsins in the
stomach, the questions about “why does the stomach not
digest itself in spite of strong lytic weapon?” and “how
does the stomach preserve its normal integrity under the
continuous exposure to melting materials that are secreted?”
had been raised. The discovery of “gastric mucosal barrier”
or “stunning defense system” might be the answers to these
questions. Secretion into the lumen including bicarbonates,
mucus,immunoglobulins,antibacterialsubstancesincluding
lactoferrin, and surface active phospholipids, gastric epithe-
lia, mucosal microcirculation, mucosal immune system, and10 International Journal of Proteomics
protective neuron, all these factors are known to contribute
to orchestrated artwork of “gastric mucosal protection.”
In the recent years, HSPs have been implicated to be an
additional factor utilized for the gastric defense mechanisms
at the intracellular level. Certain HSPs are expressed even
under nonstressful conditions and play an important role
in the maintenance of normal cell integrity, but additionally
HSPs are generally considered to improve cellular recov-
ery both by either refolding partially damaged functional
proteins or increasing delivery of precursor proteins to
important organelles such as mitochondria and endoplasmic
reticulum, through which HSPs might complete eﬃcient
mucosaldefensemechanismsandachieveulcerhealing,most
probably protecting key enzymes related to cytoprotection,
conferring HSPs as “hard worker” for stomach. On the
other hand, HSPs can play as immunogen, inﬂammation
hasting, and even carcinogen, simpliﬁed as “bad oﬀender”
especially in H. pylori infection, provoking autoimmune
gastritis, atrophy, and cancer promotion. Taken together,
HSPs are blamed of unwanted disasters after H. pylori
infection whereas are awarded by faithfulness and royalty
to gastric epithelial cells under the continuous attack of
H. pylori infection through the achievement of restitution,
regeneration, removal of faded cells, and remodeling. Bright
hope for therapeutics could be feasible through the mod-
ulation of “bad oﬀender” HSPs and enforcement of “hard
worker” HSPs in the treatment of gastric diseases.
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